Sunshine Biopharma competitorsClear all

Sunshine Biopharma's top competitors include Pyxis Oncology, Takeda Pharmaceutical, Lescarden and Agios Pharmaceuticals.
Sunshine Biopharma
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Pyxis Oncology
Pyxis Oncology
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.
Takeda Pharmaceutical
Takeda Pharmaceutical
Takeda Pharmaceutical is a biopharmaceutical company.
Lescarden
Lescarden
Lescarden Inc. researches, tests, develops, and sells medications for the control and cure of various diseases with a focus on wound healing, clinical skin care, osteoarthritis and cancer applications.
Agios Pharmaceuticals
Agios Pharmaceuticals
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
Founding Date
Founding Date
2006
Founding Date
2019
Founding Date
1781
Founding Date
1960
Founding Date
2008
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Montreal, CA HQ
Locations
HQ
Locations
Chūō-ku, JP HQ
Sydney, AU
Linz, AT
Sint Jans Molenbeek, BE
Santo Amaro, BR
Oakville, CA
Tianjin, CN
see more
Locations
New York, US HQ
Locations
Cambridge, US HQ
Employees
Employees
12300% increase
Employees
717% increase
Employees
49,57882% increase
Employees
1
Employees
48226% increase
Valuation ($)
Valuation ($)
11 m
Valuation ($)
N/A
Valuation ($)
44.2 b
Valuation ($)
3.5 k
Valuation ($)
2.8 b
Twitter followers
Twitter followers
N/A
Twitter followers
37
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1.2 k
Alexa Website Rank
Alexa Website Rank
876873
Alexa Website Rank
318518
Alexa Website Rank
118417
Alexa Website Rank
1356261
Alexa Website Rank
1070832

Financial

Revenue (est.)
Revenue (est.)
$447.2k (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$1.8b (Y, 2015)
Revenue (est.)
$119.7k (FY, 2016)
Revenue (est.)
$94.4m (FY, 2018)
Cost of goods
Cost of goods
$391.1k (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$13.1k (FY, 2016)
Cost of goods
$1.4m (FY, 2018)
Gross profit
Gross profit
$56.1k (FY, 2018)
Gross profit
N/A
Gross profit
N/A
Gross profit
$106.6k (FY, 2016)
Gross profit
$93m (FY, 2018)
Net income
Net income
($2.2m) (FY, 2018)
Net income
N/A
Net income
$83.5 (Y, 2015)
Net income
($112.7k) (FY, 2016)
Net income
($346m) (FY, 2018)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 22m
Total funding raised
$ 57.8m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Pyxis Oncology
HQ
Employees
7↑ 17% increase

Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.

View company
Takeda Pharmaceutical
HQ
Chūō-ku, JP
Employees
49,578

Takeda Pharmaceutical is a biopharmaceutical company.

View company
Lescarden
HQ
New York, US
Employees
1

Lescarden Inc. researches, tests, develops, and sells medications for the control and cure of various diseases with a focus on wound healing, clinical skin care, osteoarthritis and cancer applications.

View company
Agios Pharmaceuticals
HQ
Cambridge, US
Employees
482↑ 26% increase

Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.

View company